ClinicalTrials.gg
RecruitingNCT06371287Updated Apr 24, 2024

Effect of Musical Auditory Training on Subjects With Tinnitus Disorder

An interventional study of Treinamento Auditivo Musical and Placebo in Tinnitus, sponsored by Universidade Federal de Santa Maria. Recruiting at 2 sites in Brazil. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2024-04-24.

Sponsored by Universidade Federal de Santa Maria · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Feb 2023, registered Feb 2024).
  • Started Feb 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 20 studies in Tinnitus with a site in Brazil — 1 open to participants now, 2 under way, none of them phase 3. Tinnitus · Brazil.

Planned enrollment
16th of 16
24 · median 52
Started
2023
with 3 others
No phase
10 of 20
1 open now
Registered
15th of 20
by date
Lead sponsor
1 of 20
Universidade Federal de Santa Maria

Among the 20 studies in Tinnitus with a site in Brazil, this one is the 16th largest by planned enrollment of the 16 interventional ones that give a count, is one of 4 that started in 2023, is one of 10 with no phase, and was the 15th registered.

Tinnitus

444 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

Browse Tinnitus studies →

Open to participants now

1 of the 20 studies in Tinnitus with a site in Brazil is open now.

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Tinnitus with a site in Brazil, or all of them as a file.
02

Study summary

Among the theories of tinnitus generation, there is that of central neuroplastic changes, which reports the association between changes and reorganization that occur in central auditory pathways and impacts on associated areas due to the altered neural signal. Auditory training modifies these altered pathways through auditory exercises, which provoke positive neuroplasticity. Musical auditory training is a proposal to stimulate auditory, cognitive and metalinguistic skills with activities focused on musicality. Therefore, the objective of this study is to verify the effect of musical auditory training (MAT) on the neuroplasticity of the auditory system and the perception of tinnitus disorder in young adults.

03

Conditions studied

  • Tinnitus

Browse trials for

Keywords

  • Plasticidade Neuronal
  • Zumbido
  • Processamento Auditivo Central
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals of both sexes aged between 18 years and 55 years;
  • Complaint of chronic tinnitus (minimum perception of six months) unilateral or bilateral;
  • Hearing thresholds within normal limits bilaterally or even mild sensorineural hearing loss in the four-tone average (500, 1000, 2000 and 4000Hz);
  • Annoyance score of at least four on the Visual Analogue Scale, considered a moderate symptom discomfort;
  • Have normality in the (cognitive screening).

Exclusion criteria

Exclusion Criteria:

  • Apparent speech, psychiatric or neurological changes;
  • History of head or brain trauma;
  • Objective tinnitus (somatosensory and vascular);
  • Present symptoms and/or diagnosis of middle ear involvement;
  • Having started a new treatment (pharmacological or therapeutic) or having been diagnosed with a disease of any origin in the last month.
  • Be carrying out another intervention for tinnitus during the research;
  • Use of electronic assistive hearing devices.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Study Group - Musical Auditory Training

    For musical training, the protocol proposed by Freire, et al. (2009). This protocol was created for elderly users of hearing aids and in this study it will be used as an instrument for intervention in tinnitus, aiming at auditory training through the hierarchization of auditory skills associated with musicality (FREIRE, 2009). Eight sessions will be held over four weeks, two sessions per week. Sessions will last a minimum of 40 minutes and a maximum of 50 minutes. Victory supra-aural headphones will be used, connected to the computer. There will be calibration, with adjustment of the volume of sounds to the most comfortable level for the individual at the beginning of all sessions.

    Behavioral: Treinamento Auditivo Musical

  • Placebo comparator
    Control Group - Placebo

    Placebo sessions will also be held twice a week for four weeks, totaling eight sessions. To ensure the same conditions for performing musical auditory training, in the placebo treatment, instrumental music will be used concomitantly with the exposure of films without sound, in which patients will be exposed to visual and auditory stimulation during the same time of EG intervention, at least 40 minutes and a maximum of 50 minutes.

    Behavioral: Placebo

Interventions

  • BehavioralTreinamento Auditivo Musical

    Auditory training with a focus on musicality. The skills trained will be: figure-ground for instrumental sounds, sequential figure-ground, directed listening, duration of sounds, frequency of sounds, rhythm (temporal structuring), auditory closure and audiovisual memory, with a focus on temporal processing, working memory and attention selective on an increasing scale of difficulty. The frequency ranges of instrumental sounds are from 200 to 4000 Hz, composed of the following instruments: guitar, vibraphone, piano, flute and drum.

  • BehavioralPlacebo

    This placebo approach will be to demonstrate the influence of musical exposure without exercises with structuring auditory skills and compare with the TAM group. The song Sonata for two pianos in D major, K448, by Mozart, will be used. The films selected were: Cirque Du Soleil, entitled "The Journey of Man"; Chaplin collection with the following films: "Modern Times", "The Great Dictator", "In Search of Gold" and "Footlights". The choice of the order of the films will be random, as proposed by Freire (2009).

06

What researchers measure

Primary outcomes

  1. Changes in latency of the long latency auditory evoked potential (LLAEP)

    Improve the latency in milliseconds of P2 potential

    Time frame: Within a month

07

Study locations

2 of 2 sites recruiting
  • Universidade Federal de Santa Maria
    Santa Maria, RS 97.105-970, Brazil
    Recruiting
    • Dayane Domeneghini Didoné · Contactdayane.didone@ufsm.br · 553220-9362
    • Dayane Domeneghini Didoné D Dayane Domeneghini Didoné · Principal investigator
  • Universidade Federal de Santa Maria
    Santa Maria, RS 97.105-970, Brazil
    Recruiting
    • Dayane D Didoné, Professora · Contactdayane.didone@ufsm.br · 553220-9362
    • Christine G Schumacher, Mestranda · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2023 (actual). Primary completion is estimated for Aug 2024, 17 months after the start.

Of 133 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 17 months is close to that.

Counting every sponsor, half of 151 studies reached it within 17 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2024
First posted
Apr 17, 2024
StartActual
Feb 20, 2023
Primary completionEst.
Aug 10, 2024
CompletionEst.
Feb 10, 2025
Last update
Apr 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06371287
Lead sponsor
Universidade Federal de Santa Maria
Responsible party
Christine Grellmann Schumacher (Investigator Official, Universidade Federal de Santa Maria) — Principal investigator
First posted
Apr 17, 2024
Start date
Feb 20, 2023
Primary completion
Aug 10, 2024 (estimated)
Completion
Feb 10, 2025 (estimated)
Last update
Apr 24, 2024

Study contacts

Christine Grellmann Schumacher G Schumacher
Contact
christine.schumacher@acad.ufsm.br
553220-9362
Dayane Domeneghini Didoné D Didoné
Contact
dayane.didone@ufsm.br
553220-9362

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion